JP2011520889A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520889A5 JP2011520889A5 JP2011509571A JP2011509571A JP2011520889A5 JP 2011520889 A5 JP2011520889 A5 JP 2011520889A5 JP 2011509571 A JP2011509571 A JP 2011509571A JP 2011509571 A JP2011509571 A JP 2011509571A JP 2011520889 A5 JP2011520889 A5 JP 2011520889A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- carbapenem
- aqueous
- cyclodextrin
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5330108P | 2008-05-15 | 2008-05-15 | |
| US61/053,301 | 2008-05-15 | ||
| PCT/US2009/043295 WO2009140162A1 (en) | 2008-05-15 | 2009-05-08 | Stable pharmaceutical formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011520889A JP2011520889A (ja) | 2011-07-21 |
| JP2011520889A5 true JP2011520889A5 (enExample) | 2013-04-04 |
Family
ID=40941781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509571A Pending JP2011520889A (ja) | 2008-05-15 | 2009-05-08 | 安定な医薬製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8183233B2 (enExample) |
| EP (1) | EP2288338A1 (enExample) |
| JP (1) | JP2011520889A (enExample) |
| CN (1) | CN102026621A (enExample) |
| CA (1) | CA2722602A1 (enExample) |
| MX (1) | MX2010012451A (enExample) |
| TW (1) | TW201008594A (enExample) |
| WO (1) | WO2009140162A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007234612B2 (en) | 2006-12-14 | 2013-06-27 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein stabilization formulations |
| US7678764B2 (en) | 2007-06-29 | 2010-03-16 | Johnson & Johnson Regenerative Therapeutics, Llc | Protein formulations for use at elevated temperatures |
| JP5323832B2 (ja) | 2007-08-07 | 2013-10-23 | アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー | 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤 |
| BRPI0911048A2 (pt) | 2008-04-14 | 2015-12-29 | Atrm Llc | formulações líquidas tamponadas de gdf-5 |
| CN102614492B (zh) * | 2011-01-31 | 2013-12-11 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的液体药用组合物 |
| CN102614491B (zh) * | 2011-01-31 | 2014-04-16 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途 |
| AU2012327237A1 (en) * | 2011-12-02 | 2013-06-20 | University Health Network | Compositions of tigecycline and uses thereof |
| CA2888625A1 (en) | 2012-11-20 | 2014-05-30 | Fresenius Kabi Usa, Llc | Caspofungin acetate formulations |
| CN103330933B (zh) * | 2013-04-26 | 2015-08-05 | 江苏豪森药业股份有限公司 | 含有米卡芬净或其盐的药物组合物 |
| WO2015105720A1 (en) * | 2014-01-07 | 2015-07-16 | Hospira Inc. | Stabilised carbapenem compositions |
| CN104861043B (zh) * | 2014-05-29 | 2019-03-01 | 上海天伟生物制药有限公司 | 一种环肽类化合物的组合物及其制备方法和用途 |
| KR101587420B1 (ko) * | 2014-08-20 | 2016-01-22 | 주식회사 대웅제약 | 에르타페넴-함유 동결건조제제의 제조방법 |
| ES2694561T3 (es) * | 2015-02-23 | 2018-12-21 | Selectchemie Ag | Composición de anidulafungina |
| US10905113B2 (en) | 2015-11-12 | 2021-02-02 | Regents Of The University Of Minnesota | Compositions and method for storing liquid biospecimens |
| AU2017376960B2 (en) | 2016-12-16 | 2023-12-14 | Baxter Healthcare Sa | Micafungin compositions |
| US11968975B2 (en) | 2019-04-30 | 2024-04-30 | Regents Of The University Of Minnesota | Compositions and methods for storing liquid biospecimens |
| WO2023205165A1 (en) * | 2022-04-22 | 2023-10-26 | Brii Biosciences Offshore Limited | A polymyxin composition and methods for producing the same |
| CN117088974B (zh) * | 2023-08-14 | 2024-02-13 | 武汉健昊生物科技有限公司 | 一种抗体保存液 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2908614A (en) * | 1954-08-10 | 1959-10-13 | Glaxo Lab Ltd | Use of dextran in freeze-drying process |
| US4457916A (en) * | 1982-08-31 | 1984-07-03 | Asahi Kasei Kogyo Kabushiki Kaisha | Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same |
| EP0150067A3 (en) * | 1984-01-23 | 1986-12-30 | Takeda Chemical Industries, Ltd. | Stable composition of gamma-interferon |
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US4883785A (en) * | 1984-07-27 | 1989-11-28 | Chow Wing Sun | Complex of anti-fungal agent and cyclodextrin and method |
| ATE148165T1 (de) | 1989-07-24 | 1997-02-15 | Bayer Ag | Stabilisierung von hochgereinigten proteinen |
| JPH051075A (ja) * | 1991-06-25 | 1993-01-08 | Lederle Japan Ltd | カルバペネム化合物を安定に含有する水溶液 |
| US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
| JPH0769887A (ja) * | 1993-07-09 | 1995-03-14 | Takeda Chem Ind Ltd | ペネム化合物含有固形組成物、その製造法および剤 |
| JPH0920688A (ja) * | 1995-07-01 | 1997-01-21 | Hideyo Yamaguchi | 抗菌用剤 |
| SE9803517D0 (sv) * | 1998-10-15 | 1998-10-15 | Astra Ab | Pharmaceutical preparation |
| ES2433678T3 (es) | 1999-03-03 | 2013-12-12 | Eli Lilly & Company | Formulaciones farmacéuticas de equinocandina que contienen tensioactivos formadores de micelas |
| US7094601B2 (en) * | 2000-05-16 | 2006-08-22 | The General Hospital Corporation | Microinjection of cryoprotectants for preservation of cells |
| US20030072807A1 (en) | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
| US20030138403A1 (en) * | 2001-06-29 | 2003-07-24 | Maxygen Aps | Interferon formulations |
| US20030054042A1 (en) * | 2001-09-14 | 2003-03-20 | Elaine Liversidge | Stabilization of chemical compounds using nanoparticulate formulations |
| WO2006078066A1 (ja) * | 2005-01-21 | 2006-07-27 | Dainippon Sumitomo Pharma Co., Ltd. | 経気道呼吸器感染症治療剤 |
| EP2023895A2 (en) * | 2006-05-12 | 2009-02-18 | Adventrx Pharmaceuticals, Inc. | Pharmaceutical compositions for vein irritating drugs |
| WO2007142212A1 (ja) * | 2006-06-08 | 2007-12-13 | Dainippon Sumitomo Pharma Co., Ltd. | 製剤組成物 |
| EP2057989A1 (en) * | 2006-08-29 | 2009-05-13 | Daiichi Sankyo Company, Limited | Freeze-dried preparation of 1-methylcarbapenem |
| AU2007329333A1 (en) | 2006-12-06 | 2008-06-12 | Wyeth | High protein concentration formulations containing mannitol |
| US20080200655A1 (en) | 2007-02-16 | 2008-08-21 | Wyeth | Protein Formulations Containing Sorbitol |
-
2009
- 2009-05-08 MX MX2010012451A patent/MX2010012451A/es active IP Right Grant
- 2009-05-08 US US12/437,679 patent/US8183233B2/en not_active Expired - Fee Related
- 2009-05-08 CN CN200980117358XA patent/CN102026621A/zh active Pending
- 2009-05-08 EP EP09747247A patent/EP2288338A1/en not_active Withdrawn
- 2009-05-08 WO PCT/US2009/043295 patent/WO2009140162A1/en not_active Ceased
- 2009-05-08 JP JP2011509571A patent/JP2011520889A/ja active Pending
- 2009-05-08 CA CA2722602A patent/CA2722602A1/en not_active Abandoned
- 2009-05-12 TW TW098115697A patent/TW201008594A/zh unknown
-
2012
- 2012-04-23 US US13/453,353 patent/US20120207762A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520889A5 (enExample) | ||
| Siepmann et al. | Lipids and polymers in pharmaceutical technology: Lifelong companions | |
| SI2648520T1 (en) | Formulation of dexmedetomidine pre-mixtures | |
| WO2011034604A3 (en) | Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof | |
| JP2013525493A5 (enExample) | ||
| HK1209343A1 (en) | Etanercept formulations exhibiting marked reduction in sub-visible particles | |
| BR112015029350A2 (pt) | composição de nucleação e composição de polímero termoplástico que compreende tal composição de nucleação | |
| SG196810A1 (en) | Controlled release pharmaceutical or foodformulation and process for its preparation | |
| JP2013532677A5 (enExample) | ||
| WO2012071389A3 (en) | Stable cannabinoid compositions and methods for making and storing them | |
| MX2016007921A (es) | Composiciones de acido hialuronico que comprenden mepivacaina. | |
| JP2008543871A5 (enExample) | ||
| JP2013223715A5 (enExample) | ||
| GT200900236A (es) | Sales de adición de ácido, hidratos y polimorfos de la etil-amida del ácido 5-(2,4-dihidroxi-5-isopopril-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, y formulaciones que comprenden esta formas.- | |
| AR094770A1 (es) | Composición masticable para administración oral y proceso para preparar la misma | |
| PH12018501274A1 (en) | Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof | |
| CN101919863A (zh) | 头孢拉宗组合物 | |
| CN106456792B (zh) | 制备含厄他培南的冻干制剂的方法 | |
| WO2012161520A3 (ko) | 도세탁셀을 함유하는 액상 주사용 조성물 | |
| CN103329990A (zh) | 一种基于纳米钛白粉的水果保鲜组合物及保鲜方法 | |
| SG194458A1 (en) | Solid pharmaceutical composition | |
| CN105030663A (zh) | 一种溶液型醋酸曲安奈德注射液的制备方法 | |
| XU | Optimization of Meloxicam Nanosuspensions Fast Dissolving Sublingual Films (MLX-NS-Fdsfs) by Box-Behnken Response Surface Methodology | |
| Benez et al. | Estudo comparativo da atividade antiinflamatória, ulcerogênica e citotóxica do S-ibuprofeno e ibuprofeno racêmico | |
| Miura et al. | The effectiveness of scopolamine ointment for drooling in a patient with tongue cancer |